SOUTH SAN FRANSICO, CA, Initial Therapeutics was created by ATP with $75M in Series A funding.
Initial Therapeutics was started With $75M from Apple Tree Partners, to Create a New Kind of Drug Designed to Stop the Formation of Difficult-to-Drug Protein Targets.
Initial Therapeutics, a biotechnology company created to make medicines that block notoriously difficult-to-drug protein targets with a new mode of action: selective termination of protein synthesis.
(c) by Massinvestor, Inc. For contact info, please check out our
about page.
